# Novel Biomarkers of Thrombotic Risk

> **NCT02505217** · — · COMPLETED · sponsor: **University of Vermont** · enrollment: 200 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02505217
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2018-02-15
- **Final completion:** 2018-02-15
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02505217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02505217, "Novel Biomarkers of Thrombotic Risk". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02505217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*